BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 33741419)

  • 1. The m
    Qin Y; Qiao Y; Li L; Luo E; Wang D; Yao Y; Tang C; Yan G
    Life Sci; 2021 Jun; 274():119366. PubMed ID: 33741419
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transforming growth factor-beta1 upregulation triggers pulmonary artery smooth muscle cell proliferation and apoptosis imbalance in rats with hypoxic pulmonary hypertension via the PTEN/AKT pathways.
    Liu Y; Cao Y; Sun S; Zhu J; Gao S; Pang J; Zhu D; Sun Z
    Int J Biochem Cell Biol; 2016 Aug; 77(Pt A):141-154. PubMed ID: 27297622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. YTHDF2 mediates the mRNA degradation of the tumor suppressors to induce AKT phosphorylation in N6-methyladenosine-dependent way in prostate cancer.
    Li J; Xie H; Ying Y; Chen H; Yan H; He L; Xu M; Xu X; Liang Z; Liu B; Wang X; Zheng X; Xie L
    Mol Cancer; 2020 Oct; 19(1):152. PubMed ID: 33121495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NDUFA4L2 in smooth muscle promotes vascular remodeling in hypoxic pulmonary arterial hypertension.
    Liu Y; Nie X; Zhu J; Wang T; Li Y; Wang Q; Sun Z
    J Cell Mol Med; 2021 Jan; 25(2):1221-1237. PubMed ID: 33340241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dysregulation of microRNA-214 and PTEN contributes to the pathogenesis of hypoxic pulmonary hypertension.
    Liu H; Yin T; Yan W; Si R; Wang B; Chen M; Li F; Wang Q; Tao L
    Int J Chron Obstruct Pulmon Dis; 2017; 12():1781-1791. PubMed ID: 28684904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Notch4 mediates vascular remodeling via ERK/JNK/P38 MAPK signaling pathways in hypoxic pulmonary hypertension.
    Guo M; Zhang M; Cao X; Fang X; Li K; Qin L; He Y; Zhao J; Xu Y; Liu X; Li X
    Respir Res; 2022 Jan; 23(1):6. PubMed ID: 35016680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 5-Aza-2'-deoxycytidine, a DNA methylation inhibitor, attenuates hypoxic pulmonary hypertension via demethylation of the PTEN promoter.
    Xing XQ; Li B; Xu SL; Zhang CF; Liu J; Deng YS; Yang J
    Eur J Pharmacol; 2019 Jul; 855():227-234. PubMed ID: 31085236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppression of Akt1 phosphorylation by adenoviral transfer of the PTEN gene inhibits hypoxia-induced proliferation of rat pulmonary arterial smooth muscle cells.
    Luo C; Yi B; Bai L; Xia Y; Wang G; Qian G; Feng H
    Biochem Biophys Res Commun; 2010 Jul; 397(3):486-92. PubMed ID: 20515660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The changes of PTEN/Akt1 expression and cell proliferation in pulmonary arterial smooth muscle cells induced by hypoxia in rats].
    Yi B; Qian GS; Bai L
    Zhonghua Jie He He Hu Xi Za Zhi; 2008 Aug; 31(8):586-90. PubMed ID: 19080402
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miR-143 and miR-145 promote hypoxia-induced proliferation and migration of pulmonary arterial smooth muscle cells through regulating ABCA1 expression.
    Yue Y; Zhang Z; Zhang L; Chen S; Guo Y; Hong Y
    Cardiovasc Pathol; 2018; 37():15-25. PubMed ID: 30195228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Crosstalk between the Akt/mTORC1 and NF-κB signaling pathways promotes hypoxia-induced pulmonary hypertension by increasing DPP4 expression in PASMCs.
    Li Y; Yang L; Dong L; Yang ZW; Zhang J; Zhang SL; Niu MJ; Xia JW; Gong Y; Zhu N; Zhang XJ; Zhang YY; Wei XM; Zhang YZ; Zhang P; Li SQ
    Acta Pharmacol Sin; 2019 Oct; 40(10):1322-1333. PubMed ID: 31316183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. N6-methyladenosine modification of KLF2 may contribute to endothelial-to-mesenchymal transition in pulmonary hypertension.
    Kang K; Xiang J; Zhang X; Xie Y; Zhou M; Zeng L; Zhuang J; Kuang J; Lin Y; Hu B; Xiong Q; Yin Q; Su Q; Liao X; Wang J; Niu Y; Liu C; Tian J; Gou D
    Cell Mol Biol Lett; 2024 May; 29(1):69. PubMed ID: 38741032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MiR-19a modulates hypoxia-mediated cell proliferation and migration via repressing PTEN in human pulmonary arterial smooth muscle.
    Zhao M; Chen N; Li X; Lin L; Chen X
    Life Sci; 2019 Dec; 239():116928. PubMed ID: 31682848
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involvement of CapG in proliferation and apoptosis of pulmonary arterial smooth muscle cells and in hypoxia-induced pulmonary hypertension rat model.
    Xu X; Hu H; Wang X; Ye W; Su H; Hu Y; Dong L; Zhang R; Ying K
    Exp Lung Res; 2016 Apr; 42(3):142-53. PubMed ID: 27093378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Silencing EIF3A ameliorates pulmonary arterial hypertension through HDAC1 and PTEN/PI3K/AKT pathway in vitro and in vivo.
    Yang HT; Wang G; Zhu PC; Xiao ZY
    Exp Cell Res; 2023 May; 426(1):113555. PubMed ID: 36921705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mitofusin 2 Downregulation Triggers Pulmonary Artery Smooth Muscle Cell Proliferation and Apoptosis Imbalance in Rats With Hypoxic Pulmonary Hypertension Via the PI3K/Akt and Mitochondrial Apoptosis Pathways.
    Fang X; Chen X; Zhong G; Chen Q; Hu C
    J Cardiovasc Pharmacol; 2016 Feb; 67(2):164-74. PubMed ID: 26485208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MiR-593-5p promotes the development of hypoxic-induced pulmonary hypertension via targeting PLK1.
    Zhao TF; Wang SY; Zou XZ; Zhao HD
    Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3495-3502. PubMed ID: 31081105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. METTL3 promotes prostatic hyperplasia by regulating PTEN expression in an m
    Li J; Yao H; Huang J; Li C; Zhang Y; Xu R; Wang Z; Long Z; Tang J; Wang L
    Cell Death Dis; 2022 Aug; 13(8):723. PubMed ID: 35985997
    [TBL] [Abstract][Full Text] [Related]  

  • 19. circ‑Grm1 promotes pulmonary artery smooth muscle cell proliferation and migration via suppression of GRM1 expression by FUS.
    Sun S; Kong Q; Cai Z; Wang M; Zhao H; Zhao C
    Int J Mol Med; 2021 Nov; 48(5):. PubMed ID: 34528696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. m
    Jin D; Guo J; Wu Y; Du J; Yang L; Wang X; Di W; Hu B; An J; Kong L; Pan L; Su G
    J Hematol Oncol; 2019 Dec; 12(1):135. PubMed ID: 31818312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.